Evgeny Zaytsev is a highly accomplished venture capital investor in the life sciences industry. He has successfully realized investments in top companies such as Atea Pharmaceuticals, Leap Therapeutics, Clearside Biomedical, Transcend Medical, and Invuity. Zaytsev has a PhD in Physiology and an MD in General Medicine from Altai State Medical University. He also has an MBA in Business from Stanford Graduate School of Business.

Zaytsev is a Co-Founder and Managing Partner at Bering Capital, where he oversees investments in the healthcare sector. He has held board positions at companies such as Epic Sciences, Novadigm Therapeutics, Atea Pharmaceuticals, Tragara Pharmaceuticals, Clearside BioMedical, Aldea Pharmaceuticals, InteKrin Therapeutics, and Sonoma Orthopedic Products. Additionally, he has served as Managing Partner at RMI Partners, Co-Founder and General Partner at Helix Ventures, and Healthcare Portfolio Advisor at Asset Management Company.

Zaytsev has also held several leadership positions outside of his professional endeavors. He was the President of the American Business Association of Russian Professionals (AmBAR), the Founder and President of US-Russia Technology Symposium at Stanford University, and the Executive Secretary and Board Member at "Semipalatinsk Test Site/Altai" National Program. He also served as the Chief Scientific Officer at the Medico-Ecological Institute in Barnaul, Russia.

In summary, Evgeny Zaytsev is a highly accomplished venture capital investor with a vast professional and academic background in the healthcare industry.

---